NICE guideline on chronic heart failure

NYHA Score: Functional Classification of Heart Failure

Investigation and management of congestive heart failure

 

New York Heart Association classification of congestive heart failure and associated evidence based treatments

Class Symptoms Treatment if left ventricular ejection fraction is low Treatment if left ventricular ejection fraction is preserved
Class I (mild) No limitation of physical activity; ordinary physical activity does not cause undue fatigue, palpitation, or dyspnoea (shortness of breath) ACE inhibitor*; consider a β blocker{dagger}  
Class II (mild) Slight limitation of physical activity; comfortable at rest, but ordinary physical activity results in fatigue, palpitation, or dyspnoea ACE inhibitor; β blocker; candesartan§ (specialist advice needed if adding to an ACE inhibitor) Candesartan (specialist advice needed)
Class III (moderate) Marked limitation of physical activity; comfortable at rest, but less than ordinary activity causes fatigue, palpitation, or dyspnoea ACE inhibitor; β blocker; candesartan (specialist advice needed if adding to an ACE inhibitor); spironolactone{ddagger}; digoxin Candesartan (specialist advice needed)
Class IV (severe) Cannot carry out any physical activity without discomfort; symptoms of cardiac insufficiency at rest; discomfort increases if any physical activity is undertaken ACE inhibitor; carvedilol or bisoprolol as β blocker; spironolactone{ddagger}; digoxin Candesartan (specialist advice needed)

 

  BHF factfiles

 

Left ventricular systolic dysfunction

Diagnosis in patients with suspected heart failure in primary care:

Major ECG abnormality:
  • AF
  • Previous MI
  • LVH
  • LBBB
  • LAD
  Major CXR abnormality:
  • Significant cardiomegaly
  • Pulmonary congestion

Detailed protocol:

Cardiac resynchronisation therapy for chronic heart failure and conduction delay

Cardiac resynchronisation therapy for chronic heart failure and conduction delay

 

Diastolic heart failure

Management